PharmaSGP Holding SE (XTER:PSG) ROE % Adjusted to Book Value : 9.25% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PharmaSGP Holding SE ROE % Adjusted to Book Value?

PharmaSGP Holding SE's ROE % for the quarter that ended in Sep. 2024 was 61.80%. PharmaSGP Holding SE's PB Ratio for the quarter that ended in Sep. 2024 was 6.68. PharmaSGP Holding SE's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 9.25%.

PharmaSGP Holding SE ROE % Adjusted to Book Value Historical Data

The historical data trend for PharmaSGP Holding SE's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaSGP Holding SE ROE % Adjusted to Book Value Chart

PharmaSGP Holding SE Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

0.73

4.75

4.37

6.82

PharmaSGP Holding SE Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															7.11	7.33	7.35	5.00	9.25

Competitive Comparison of PharmaSGP Holding SE's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaSGP Holding SE's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaSGP Holding SE's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaSGP Holding SE's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where PharmaSGP Holding SE's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

PharmaSGP Holding SE ROE % Adjusted to Book Value Calculation

PharmaSGP Holding SE's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	46.29%	/	6.79
	=	6.82%

PharmaSGP Holding SE's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	61.80%	/	6.68
	=	9.25%

PharmaSGP Holding SE ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of PharmaSGP Holding SE's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaSGP Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaSGP Holding SE (XTER:PSG) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lochhamer Schlag 1, Graefelfing, Munich, DEU, 82166

Website

https://www.sgp-pharma.com

PharmaSGP Holding SE is a pharmaceutical company. The company develops chemical-free, over-the-counter (OTC) drugs and healthcare products. The product portfolio includes RUBAXX for rheumatic pain Restaxil for nerve pain, and Deseo for sexual dysfunction. It has established various consumer brands in important indication areas, such as rheumatic and neuralgic pain or sexual weakness Also, the company offers products for skin aging and vertigo.

Executives

Dr. Clemens Fischer	Supervisory Board
Madlena Hohlefelder	Supervisory Board

PharmaSGP Holding SE Headlines

No Headlines